Educational & Research Use Only. Not medical advice. Compounds are research-grade and not FDA-approved unless explicitly noted.
13
Section 13 · 3 compounds

Skin, Hair & Dermal Signaling

Signal peptides and pathway modulators studied in skin structure, cosmetic science, hair-follicle biology, and tissue regeneration.

Home/ Sections/ Skin, Hair & Dermal Signaling

This section focuses on peptides and pathway modulators investigated primarily in dermal extracellular-matrix signaling, cosmetic formulation science, hair-follicle biology, and tissue regeneration. Evidence in this category is often route-specific and may be preclinical or cosmetic rather than therapeutic.

Click any compound below to expand. Each entry separates chemical identity, mechanism, evidence level, and important limitations.

Pal-KTTKS · Matrikine-Inspired Cosmetic Research

Matrixyl is a trade name historically associated with palmitoyl pentapeptide-4 (Pal-KTTKS). It combines the KTTKS pentapeptide sequence with a palmitoyl lipid group and has been investigated primarily as a topical cosmetic signal peptide in skin-aging and extracellular-matrix research.

What It's Being Studied To Do

  • Study fibroblast and extracellular-matrix signaling
  • Evaluate procollagen- and matrix-related responses in skin models
  • Measure changes in wrinkle and fine-line appearance in topical cosmetic studies
  • Investigate how lipid modification affects peptide delivery into skin formulations

Why This Matters

Fragments generated during extracellular-matrix remodeling can act as biological signals. Pal-KTTKS research explores whether a synthetic, lipid-linked version of such a signal can influence fibroblast activity and visible features of photoaged skin.

Evidence & Research Context

Controlled human cosmetic studies have reported improvements in wrinkle-related measures with topical pal-KTTKS formulations. Those findings are route- and formulation-specific: they do not establish safety or efficacy for injection or systemic use. Also, “Matrixyl” is used commercially for more than one branded peptide system, so chemical identity should be confirmed as palmitoyl pentapeptide-4 before applying this evidence.

Related Research

GHK-Cu · dermal and wound-repair signalingAHK-Cu · copper-peptide researchSNAP-8 · cosmetic neuropeptidePTD-DBM · hair-follicle pathway research

Acetyl Octapeptide-3 · Topical and Delivery-System Research

SNAP-8 is the trade name for acetyl octapeptide-3, a synthetic cosmetic peptide designed around SNAP-25/SNARE-associated neurotransmitter-release biology. It is studied mainly in topical cosmetic and transdermal-delivery formulations intended to influence the appearance of expression-related wrinkles.

What It's Being Studied To Do

  • Investigate SNARE-associated mechanisms involved in neurotransmitter vesicle release
  • Study cosmetic approaches to reducing the appearance of dynamic facial lines
  • Evaluate peptide delivery through topical or microneedle systems
  • Compare multi-peptide formulations used in cosmetic skin research

Why This Matters

Expression lines are influenced by repeated muscle contraction as well as changes in dermal collagen and elasticity. SNAP-8 research asks whether a small peptide can modulate part of the signaling machinery associated with contraction-related wrinkle formation.

Evidence & Research Context

Human studies involving acetyl octapeptide-3 generally use multi-ingredient topical or microneedle formulations, which makes it difficult to isolate the contribution of SNAP-8 itself. Claims of equivalence to botulinum toxin are not established. The major translational question remains whether a given formulation delivers enough intact peptide to the relevant tissue.

Related Research

Matrixyl · dermal matrix signalingAcetyl hexapeptide-8 · related cosmetic SNARE researchGHK-Cu · skin-repair signalingMicroneedle delivery systems · peptide penetration research

Wnt/β-Catenin Signaling · Hair-Follicle Regeneration Research

PTD-DBM stands for protein transduction domain–Dishevelled binding motif. It is an engineered peptide designed to disrupt the interaction between CXXC5 and Dishevelled (DVL). Because CXXC5 can inhibit Wnt/β-catenin signaling through this interaction, PTD-DBM has been used experimentally to release that inhibitory brake.

What It's Being Studied To Do

  • Activate Wnt/β-catenin signaling by disrupting CXXC5–DVL binding
  • Study hair regrowth in androgenetic-alopecia and other animal models
  • Investigate wound-induced hair-follicle neogenesis
  • Explore cutaneous wound-healing and tissue-regeneration pathways

Why This Matters

Wnt/β-catenin signaling is central to hair-follicle development, cycling, and tissue regeneration. PTD-DBM is mechanistically interesting because it targets a protein-protein interaction within an inhibitory pathway rather than supplying a growth factor directly.

Evidence & Research Context

Published studies report hair-regrowth and follicle-neogenesis effects in mouse and other preclinical models, including work linking CXXC5 signaling to androgenetic alopecia. Human efficacy, pharmacokinetics, optimal formulation, and long-term safety have not been established. PTD-DBM should therefore be presented as preclinical research, not an established hair-loss treatment.

Related Research

Wnt/β-catenin signaling · follicle-regeneration pathwayCXXC5 · negative Wnt regulatorGHK-Cu / AHK-Cu · dermal and hair researchMatrixyl · dermal signaling peptide
← 12 · Oxidative Stress & Detoxification Support